[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"2f390492c4b6d659645d153e2a5f5979beea13a7a3069937d1e187a035ee31d9","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"2f390492c4b6d659645d153e2a5f5979beea13a7a3069937d1e187a035ee31d9","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"7c9a1e267529439926aa6c869ceac293fb33c3a70dda8e4d45620979854e2b63","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"7c9a1e267529439926aa6c869ceac293fb33c3a70dda8e4d45620979854e2b63","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"d1bbbf3fc8ae7fbc6e9bde9e14766e646aa4d58285e312e5ba0e7aad33271b06","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"8e9375a32cebb847780ab0f31ee40e484c4e1e3c78a52cf55ed8a07b8896b91d","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"48e37abb199f1e1787c3996a22c2c089c619a64021f9afb405412cc2dea18193","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"c0ba96578391d2f2073257bfd0b0528e24c13ff10fa937e1da7baaedde5a38a9","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"4c6d57fe20071f3479aee534ee6dfc32f7a82162b3358a61a84fc8458588df66","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"1b1e62d11494fc9c68c82615397b009a2938a6a523be1bdd54f9d2fddee96f0b","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"0c162f7b2d8c58e92e7b8b31f4aa147d830290fb4fde2c413eda7bddb5afce40","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"74d0432f4077a6bf71ed2e97ecc8c386b49953a5178918d0d817a29d46d0e5af","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"1e6afe03d685e5282efaa006c2255d289308e40d710baaed680877b09f3019d0","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"aaf9b5f21dcdc924ab940256d8ddd371c6b8000f1ac1675aa480b8517d8f9b80","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"4c9c6b3708fd5e5b6b5d1469495371c1729fe10929b9fb0e60d2679ef186d183","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"ccea5e43cbb7a2007cd7d3aa15c499e50bc6c611c620cc7f10b5064e65c535b6","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"ddaa17d0df6d0cbfcb2883d51af7f31ac40407420f53ee8071e34908eaf19261","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"1580d09f97f7ba29527539de19cf9bf5a35094fa5b6fdba6565d775176006082","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"3365a1eceb0bb84a1510b782cc825c613abfc0e9630dbe0d3b7026fcfa9dd426","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"c01f437f1a0218428134cab66954630db5b60b408af2b9c91b820232eaaf19c3","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"a6eaaa1d81d3b235c8fef0e73772f8823dca295ac9185bc343d778deb7ca11c7","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"11483fe8b0ac5d799ce3e9359b7ebd2aef589c2634d17d8f33fadc6cb0f5aaa7","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"7ed523087b07a119f2ecde1e649f6d819dcf6eec223f4f9ad36801eb7d2fb8a4","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"cd25f66a3f2b1c17cb5f64058bebd9ecbbf8f6978b1128ee3511170736686d75","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"78496f9e80d2a114a751f31536511c1298efd95b67e159ea54d42110fc0be140","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"dc5bc887385076078343c8ea63bfc39a69ad2b076f2406a32c5067c1da878117","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"94e618eb51458832a0a895adff13852f9e29cf9cc9d6777a53b1abab26581247","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"7ffb1c502e7423b03ff7955b6ad2e3df2a05a1137e8fa07f999660065e8872e0","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"5ec2dc87bbca2dca39634c128b0e2c68d95a7745989adb564f7ef40c509385a1","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"d99925037897b5268ff9f6bf0904957b0423447c6b96cc7f7067d3cafa6ea80a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"254954a0e640da1005f9c394d54c8f65fd4750914c4962d32167a1e92c088c64","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"630cdc291453af14e8a58c9ba9d7e184837fe0646ae0893a4c1011e8584943b0","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"e4fbef57b47bd64fd26479dafcdb1288df0b0c528932fd47631da7bc1bba1999","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"928adc801ba806085269ea7fd5c345abba97abcce145030e91f9e51d6d345286","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"45b960e3b4382331c9d39b6b61a899f998482a6cc3d5ca5ea814ebdb1efc6e5a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"a474dcee2b123ec9b156569868878f5f20d814e72481bc1c45907f45b8c19d62","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"f527384a20908d1ba3960f99c4852ae830e701406f100b9bbe6a87aa546f0d70","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"f668226b17798813c6ddfce6c50302d963c95deb3ea7af82ca5fd9de23e75b5f","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"bbccff2df84c76c9ada2e7c1cc4c45fb0c106c1f4157d8da46e9baf4ce1f8c1f","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"e7e18f7739f5f7e3ae60579c3490cc1610b3e4f4c3fb419b10d4e928e2213065","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"2796411ad59fc02c18b230ecea0f2c8ca642d91d8bb4dc995ae2f507c5cc5125","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"f5e54755e8ed2c65703c5016d9ee1a77f6855fa20bed8761caa2cc94d2ab6570","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"18b804a69d447bffdca6d475057ed65d383cf87f3f28079d1ab0710dfa622074","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"14dca4663dee3d26f35e3ec4cb68bd826aab6c648430eb5d87c35eb321de2b3b","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"cf2a546ea2f69fc8cd159b99ad4a7a19f64308097eeb9dfc0fdd5b196ff47621","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"c984a186addceef73c23d56a01f2e0d98adb67fae13bb62160dcefed67d4f46a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"857c1abf6832faa306d5db496146bd2e305c9cff379d757c4a8508bd8377e8c2","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"9fa84123e8b9fdcbe0ca95d24ce4e3f3ec3bf0b0fba3e406d14cba21e3434c55","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"f7d5b451181c6de27cb35f39fabfe757af60ac26da00981a37b88d896cc2a51d","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"64d1c862f8746da3da5b7fc5806f2b97d7c100d43ab78e5e97581ea6a154bc8c","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"87affb1466566c4db6a0c183953981dcae0989869e89921d57c5166acf206604","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"b6ca0abb388119f8cc74fcbcf90e340a202f4a1ad196c566f4de74991f4decb1","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"b87b4bc17cd26e2418cc97566c028bcd9d362fe3ea1bf952d93704096e23460a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"bfbf1910e503a1bdda397e7e6e31b8fa001fc1215c9ecdbdf73ce2598dbf8d9a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"841dbde321592f76fb071d564f0424880ac3707d70875e838eb65032995ac724","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"a066cf4bc88e6789fc3aaa296fded0856451d50ace53367828c9f3804916c4b9","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"21ea5fa08bf7f64cef8406030a347a3b14af98ada89110115e500231dc59f24f","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"054685d813a21bb5da1b5cfeaaeafe4a5c5e627753efa377d6ec3c9ca1edd3ff","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"e0a85037cdb57deb0e9a7f8df2636e4ab287e671de97032eaa220302e591eb48","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"c160e0a7fbe9688c708ec89c9dd8e50ac0a36454fb041af1f825555bada66366","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"fa464d2171f06381e8eac3c58632edab10543ee009781f5cb26df13e17f44610","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"bb4f7b827068f2836040f9e626cb8c2f89894b56133ee4b48a36f337de25979a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"a4b9fc15c716a7cb682fe110977a27973d095c97b463f06432ffeb0edb1a8b18","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"5472052da0fa8d053413d1fead89c17bea28df2a07ef482b30322005f572f190","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"7e555e28dc190159b7211934747f567d129cdccd2a2d3b032575c1e089857208","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"763a399263b19eabf941e2c7f4d08ff8115a7073b9b2c172ee080140053fef66","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"857c1abf6832faa306d5db496146bd2e305c9cff379d757c4a8508bd8377e8c2","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"dfb100e552775d2f98bc456a741491e5bd724cfbfe1bd2b43ba269dbf4e296bc","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"40aef5d54d1aad0c4cd78b17e581089ffc76cf837598b54a44cc2a07e81af89a","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"fb0abb8f1379ce33614b5c87e013b9647dce20a82b51348066111c31c431c5ac","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"66e719e796a8fe85458d42115ea6d9ba1e9f33ce6f8936b157607e364e386520","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"4bfde65564a542462c0c63111842c9a2d9ae2f6b3e1369378f74413006c0d6ec","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"b0b2897bee239173c2c00c11c489b08e6db7d980f1421a59536e47b39887406f","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"342305fc68cbf8e9ea609d8b60647acea0ca06ccb6c1e4980835806a27f4da0c","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"58fcba5108e06c82d0531f37364e6657f3336798e63c81988161d873911ef5d4","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"685a5f4ed572700d929650de72ec419b790c188a4874bd913aa21679dc90fb68","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"3b6ff945863fcf6bfd7dc9acd82c0840ef5221991ecb7cd0997ce38679f8f446","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"df3cac4872f983e563ac20b476dfff0b10cc1869ef03412ef95d6484000c1221","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"aadfb2961b08b8a1488413bfb08a37ae27a475b9a6bea30e72b9743d35e8e5ed","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"9d817309df9e1fd418a6009d580f78730393989aa1266c79990fcdc55f8f494e","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"2603e5f4a33739580d2e0419f4d675aa1237015f24757efbc62a161cbe88ad79","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"7cdaf0c3a066941c96ef810a0fe8e852b35bfe8033976451d10982ee7a4eb97c","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"a9f0c7a47571198b715be26141bd4978bd62bf48ac67823657feae339935ddf1","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"68e7cb654b9c5fb8cf2ce49baf8b01e6b4b67183d5ccf57399d7db6ff1f98c43","course_id":"HONCOL 911","course_uid":"course_1c8786792286bf715d15c06d","catalog_version_id":"c6d72af237bde3525704eb28802487269eb5ac4ff382eeaa54bf0f726a59ffe3","course_number":911,"subjects":["HONCOL"],"title":"TUMOR IMMUNOLOGY AND CANCER IMMUNOTHERAPY","description":"Gain a greater understanding of the basic and translational science that is fueling the ongoing immuno-oncology revolution in cancer care. Explore the tumor-immune microenvironment and modern approaches to cancer immunotherapy. Evaluate pertinent primary literature in this arena and exposure to the technological resources (e.g. flow cytometry, clinical pathology, cell therapeutics infrastructure) that are critical to implementing immunotherapies in the clinic. Tumor board attendance will highlight the clinical reasoning and toxicity management in the clinical use of immunotherapies for cancer treatment.","requirements_text":"MED SC-M 810,811,812, and813"}]